This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis
Nature Cancer Open Access 03 August 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Lerner, E. et al. A novel MHC-independent mechanism of tumor cell killing by CD8+ T cells. Preprint at bioRxiv https://doi.org/10.1101/2023.02.02.526713 (2023)
Related article
Peeters, B. W. A. Preprint Journal Club. PreprintClub https://www.preprintclub.com/preprint-reviews/2023-feb-lerner (2023)
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Peeters, B.W.A., Gillespie, G.M. Adaptive meets innate: CD8+ T cells kill MHC-I-negative tumour cells. Nat Rev Immunol 23, 272 (2023). https://doi.org/10.1038/s41577-023-00872-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41577-023-00872-y